Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.94 | N/A |
| PEG Ratio (TTM) | 6.57 | N/A |
| P/S Ratio (TTM) | 3.39 | N/A |
| P/B Ratio (TTM) | 1.83 | N/A |
| P/FCF Ratio (TTM) | 114.52 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.02 | N/A |
| Price to 5YR AVG FCF Ratio | 33.20 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.53% | N/A |
| ROE (TTM) | 16.61% | N/A |
| Net Profit Margin (TTM) | 28.10% | N/A |
| ROIC 5YR AVG | 58.79% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.93% | 88.52% | 60.96% |
| Revenue | 10.11% | 23.32% | 40.62% |
| Net Income | 3.37% | 79.07% | 54.76% |
| Cash Flow | 107.03% | 67.90% | 41.01% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.45 | N/A |
| Quick Ratio (TTM) | 2.45 | N/A |
| D/E Ratio (TTM) | 0.86 | N/A |
| Interest Coverage (TTM) | 0.80 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.59 | N/A |
| LTL to 5YR AVG FCF | 16.70 | N/A |
| Shares Outstanding Growth 5YR AVG | -3.40% | N/A |